How to Get AndroGel in Minnesota: Prescriptions, Telehealth, and Pharmacies

At a glance
- Drug / testosterone gel (AndroGel 1% and 1.62%), AbbVie
- Telehealth prescribing in MN / Yes, permitted under Minnesota telemedicine law
- Compounding option / Yes, via licensed 503A pharmacies in Minnesota
- Medicaid coverage / Covered with prior authorization for male hypogonadism
- Prescribers / MDs, DOs, NPs, and PAs with DEA Schedule III authority
- Key lab before Rx / Total testosterone drawn before 10 a.m. on two separate mornings
- Typical time to first dose / 7 to 14 days from initial consultation
- Standard dosing / Once daily, applied to shoulders, upper arms, or abdomen
- Transfer Rx / Yes, any licensed Minnesota pharmacy can accept a transferred testosterone gel prescription
What AndroGel Is and Why It Requires a Prescription
AndroGel is a hydroalcoholic testosterone gel available in two concentrations, 1% (delivering 25 mg or 50 mg per actuation) and 1.62% (delivering 20.25 mg or 40.5 mg per actuation). The FDA approved the 1% formulation in 2000 and the 1.62% formulation in 2011, both for adult males with hypogonadism confirmed by clinical signs and low serum testosterone. 1 Because testosterone is a Schedule III controlled substance under the Controlled Substances Act, a DEA-registered prescriber must authorize every fill and every refill. 2
Hypogonadism affects roughly 2 to 6 percent of men overall, rising sharply after age 45. 3 The Testosterone Trials (TTrials), a coordinated set of seven double-blind, placebo-controlled studies in 788 men aged 65 and older with a total testosterone below 275 ng/dL, demonstrated that testosterone treatment produced meaningful improvements in sexual function, physical performance, and bone density over 12 months compared with placebo. 4 That dataset remains the most rigorously controlled evidence base for prescribing testosterone gel in older men.
Minnesota does not impose additional state scheduling on testosterone beyond federal law. A prescription from any state-licensed, DEA-registered clinician is therefore valid at any licensed Minnesota pharmacy.
Minnesota Telehealth Law and AndroGel Prescribing
Minnesota allows telehealth prescribing for Schedule III controlled substances, including testosterone gel. The Minnesota Telehealth Act (Minn. Stat. § 62A.673) requires that the prescribing clinician establish a valid patient-provider relationship before issuing any prescription, but it does not mandate an in-person visit for that establishment. 5 A synchronous audio-visual encounter, combined with a verified lab result, satisfies the relationship requirement under current Minnesota Board of Medical Practice guidance.
Telehealth platforms operating in Minnesota must hold a valid Minnesota medical or advanced-practice license for the clinician conducting the visit. Platforms registered in other states cannot prescribe to Minnesota residents unless the individual clinician holds a Minnesota license or a Minnesota telemedicine registration. Checking licensure status takes under two minutes at the Minnesota Board of Medical Practice lookup tool before you book any appointment.
The practical steps for a telehealth AndroGel prescription in Minnesota are straightforward. First, order or complete a hormone panel at a local lab draw site. Second, schedule a video consultation. Third, if testosterone is confirmed low and clinical signs are present, the clinician sends the prescription electronically to your chosen pharmacy. Most platforms complete this sequence in five to ten business days from lab draw to prescription transmission.
Required Labs Before AndroGel in Minnesota
Two morning total testosterone measurements are the minimum standard before any responsible prescriber in Minnesota will write for AndroGel. The American Urological Association's 2018 guideline on testosterone deficiency states: "Clinicians should use a total testosterone level below 300 ng/dL as a reasonable cut-off in support of the diagnosis of low testosterone." 6 Levels must be drawn before 10 a.m. because testosterone peaks in the early morning hours and falls by 25 to 35 percent by midafternoon, which can produce a false-positive low reading if timing is ignored. 7
A complete baseline panel for AndroGel typically includes:
- Total testosterone (two separate morning draws)
- Free testosterone or sex-hormone-binding globulin (SHBG)
- Luteinizing hormone (LH) and follicle-stimulating hormone (FSH) to classify primary vs. secondary hypogonadism
- Hematocrit and hemoglobin (testosterone raises red-cell mass; a baseline above 50% is a relative contraindication) 8
- Prostate-specific antigen (PSA) for men over 40 (active or suspected prostate cancer contraindicates testosterone therapy) 1
- Comprehensive metabolic panel (liver enzymes and renal function)
- Estradiol (topical testosterone converts peripherally to estradiol; a baseline guides dose adjustments)
Most commercial labs in Minnesota, including LabCorp and Quest Diagnostics locations throughout the Twin Cities, Duluth, Rochester, and St. Cloud, complete this panel within 24 to 48 hours. Telehealth platforms often provide a lab requisition form that you take to the nearest draw site, keeping the process fully remote except for the blood draw itself.
How a Minnesota Clinician Diagnoses Hypogonadism
Low testosterone on paper alone does not equal a prescription. Responsible prescribing requires biochemical confirmation plus at least one symptom from the clinical picture: reduced libido, erectile dysfunction, decreased energy, depressed mood, loss of muscle mass, or increased fat mass. 9 The Endocrine Society's 2018 clinical practice guideline recommends against testosterone treatment in men with age-related declines who are otherwise healthy and have testosterone levels within the normal range. 9
Secondary causes of low testosterone also need ruling out before the first prescription. Prolactinoma, hemochromatosis, Klinefelter syndrome, and opioid-induced hypogonadism all require different management. That is why LH and FSH are included in the baseline panel rather than skipped to save cost.
Once the diagnosis is confirmed, the clinician selects the starting dose. For AndroGel 1.62%, the FDA-approved starting dose is 40.5 mg (two pump actuations) applied once daily to the shoulders or upper arms. 1 Dose titration occurs at 14 days and again at 28 days based on a morning testosterone drawn two hours after application.
Who Can Prescribe AndroGel in Minnesota
Minnesota permits MDs, DOs, nurse practitioners (NPs), and physician assistants (PAs) to prescribe Schedule III controlled substances, provided each holds an active DEA registration in addition to their state license. 10
NPs practicing under a collaborative agreement in Minnesota may prescribe controlled substances independently if the agreement explicitly includes Schedule III authority. PAs similarly require written delegation from a supervising physician that covers Schedule III medications. In practice, most telehealth platforms that specialize in testosterone replacement therapy employ physicians or NPs with full Schedule III authority, so patients rarely encounter a prescribing barrier.
Endocrinologists, urologists, and men's health specialists in Minnesota's major metros (Minneapolis, St. Paul, Rochester, Duluth) routinely manage TRT panels. Primary care physicians also prescribe AndroGel, though some refer complex cases to specialists for the initial workup.
The HealthRX clinical team uses the following three-gate framework when evaluating Minnesota patients for AndroGel eligibility:
Gate 1 (Biochemical): Total testosterone below 300 ng/dL on two separate morning draws, or free testosterone below 65 pg/mL when SHBG is elevated.
Gate 2 (Symptomatic): At least two symptoms from the Androgen Deficiency in Aging Males (ADAM) questionnaire, with libido decline or fatigue scoring as the most sensitive indicators for clinical significance.
Gate 3 (Safety Clearance): Hematocrit <50%, PSA <4 ng/mL (or stable with recent urology clearance), no active cardiovascular event in the prior six months, and no untreated sleep apnea.
All three gates must be open before a prescription is transmitted. This framework reduces unnecessary prescribing and protects patients from the cardiovascular and hematologic risks associated with supraphysiologic testosterone levels. 11
Prior Authorization for AndroGel in Minnesota
Minnesota Medicaid (Medical Assistance) covers AndroGel for male hypogonadism with prior authorization. The PA criteria typically require: a diagnosis code of E29.1 (testicular hypofunction) or E23.0 (hypopituitarism), two total testosterone lab values below 300 ng/dL drawn on separate mornings, documentation of at least one symptom of hypogonadism, and a trial of generic testosterone gel if AndroGel brand is specifically requested. 12
Commercial insurance plans in Minnesota vary. United Healthcare, BlueCross BlueShield of Minnesota, and Medica typically require similar PA documentation. Denial rates drop sharply when the prescriber submits both morning testosterone values, the symptom documentation, and a clinical note explaining why brand-name AndroGel is medically necessary over generic alternatives. If the PA is denied, a peer-to-peer call between the prescribing clinician and the insurance medical director resolves most cases within three to five business days.
Without insurance, a 30-day supply of AndroGel 1.62% (a 75 g pump) has a cash price of approximately $380 to $450 at major Minnesota pharmacies. Generic testosterone gel 1% can be filled for $30 to $90 with GoodRx discounts at CVS, Walgreens, and Hy-Vee locations across the state. The bioequivalence between brand and generic testosterone gel is established by FDA standards, so therapeutic outcomes are not meaningfully different. 13
503A Compounding Pharmacies in Minnesota
Minnesota-licensed 503A compounding pharmacies may legally prepare testosterone gel for individual patients when a licensed prescriber determines that the commercially available formulations do not meet a specific patient need, such as an allergen in the base, a required concentration outside the 1% or 1.62% options, or a delivery vehicle that improves absorption in an individual patient. 14
503A pharmacies compound for individual prescriptions only; they do not manufacture in bulk. A valid, patient-specific prescription from a DEA-registered Minnesota clinician is required. Compounded testosterone gel is not FDA-approved, which means it has not undergone the same efficacy and manufacturing quality review as AndroGel. The American Urological Association notes that compounded testosterone preparations may vary in potency and sterility compared with commercially manufactured products, and patients should be counseled accordingly. 6
Several 503A pharmacies with Minnesota Board of Pharmacy licenses, including locations in Minneapolis and the broader Twin Cities metro, can ship compounded testosterone gel within Minnesota when the prescription and patient address are both in-state. Shipping across state lines requires the receiving state's pharmacy board to permit mail-order controlled substances from out-of-state compounders, which adds regulatory complexity.
How to Transfer an Existing AndroGel Prescription to Minnesota
A testosterone gel prescription issued in another state may be transferred to a licensed Minnesota pharmacy under federal pharmacy law, provided: the original prescription was written by a DEA-registered clinician, the prescription has refills remaining, and Schedule III prescriptions have not already been transferred (federal law allows one transfer of a Schedule III prescription between pharmacies). 15
The receiving Minnesota pharmacist calls the original dispensing pharmacy to verify the prescription. No clinician visit is required solely for the transfer, but if the original prescription has no refills remaining, the patient needs a new prescription from a Minnesota-licensed or telehealth-eligible clinician. Most telehealth platforms can issue a new prescription within one to three business days if current labs (drawn within the past six months) confirm continued clinical need.
Patients relocating to Minnesota from states with more restrictive telehealth rules should note that Minnesota's permissive telehealth framework means they have more options, not fewer, for ongoing management once they establish in-state care.
Timeline: From First Inquiry to First Dose
Most Minnesota patients move through four stages before applying their first dose of AndroGel:
Stage 1 (Days 1 to 2): Select a telehealth platform or book an in-person appointment. Receive a lab requisition or order labs through your primary care provider.
Stage 2 (Days 2 to 5): Complete the blood draw at a local lab. Results return to the clinician within 24 to 48 hours.
Stage 3 (Days 4 to 8): Complete the video or in-person consultation. The clinician reviews labs and symptoms. If criteria are met, the prescription is transmitted electronically to your chosen pharmacy.
Stage 4 (Days 5 to 14): Pharmacy fills and dispenses. Mail-order pharmacies typically ship within two to three business days. Local retail pharmacies in Minnesota can fill same day or next day if AndroGel or generic testosterone gel is in stock.
Patients requiring prior authorization add three to seven business days to Stage 4. Urgent cases sometimes obtain a 15-day bridge supply while the PA processes.
Monitoring After Starting AndroGel in Minnesota
The FDA-approved labeling for AndroGel specifies that total testosterone should be measured in the morning, two hours after application, at 14 days and at 28 days after starting therapy, then every three to six months once stable. 1 Hematocrit must be checked at three months and six months, then annually, because testosterone stimulates erythropoiesis and can raise hematocrit above the 54% threshold that raises venous thromboembolism risk. 16
PSA monitoring is required per the Endocrine Society guideline at three months, then at 12 months, then per standard age-appropriate screening intervals. 9 A PSA rise greater than 1.4 ng/mL above baseline within any 12-month period warrants urology referral before continuing therapy.
Transfer of AndroGel to skin-contact partners or children is a documented safety risk. The FDA added a black-box warning in 2009 after reports of virilization in children who had secondary exposure through skin contact. 1 Patients should apply the gel, let it dry for five minutes, cover the application site with clothing, and wash hands thoroughly before touching others. Showering within six hours of application reduces systemic absorption and should be avoided during that window.
The TTrials data showed that men treated with testosterone had a 16% higher rate of any cardiovascular event compared with placebo at 12 months in the cardiovascular sub-trial, though this did not reach statistical significance at P = 0.22. 4 Clinicians should review cardiovascular risk factors at every monitoring visit and adjust therapy if new risk factors emerge.
Cost Reduction Strategies for Minnesota Patients
Several practical options reduce out-of-pocket cost for AndroGel in Minnesota:
Generic testosterone gel 1% at major Minnesota pharmacy chains with a GoodRx coupon costs $30 to $60 for a 150-gram tube, covering 30 days at a 50 mg daily dose. This option bypasses brand-name PA requirements entirely for most patients. 17
AbbVie's AndroGel savings program may reduce copays to as low as $10 per month for commercially insured patients who meet income eligibility. The program does not apply to Medicaid or Medicare Part D beneficiaries.
Minnesota's 503A compounders often fill testosterone gel at $40 to $80 per month for custom concentrations, which can be cost-effective when the commercial formulations require dose adjustments that are otherwise difficult to achieve.
Medicare Part D plans in Minnesota vary. Testosterone gel is on most formularies at Tier 3 or Tier 4, meaning a 30-day supply costs $45 to $120 depending on plan design. Patients in the coverage gap should ask their prescriber about generic substitution to reduce cost.
Frequently asked questions
›How do I get an AndroGel prescription in Minnesota?
›What labs are needed before AndroGel in Minnesota?
›Are there telehealth providers in Minnesota prescribing AndroGel?
›How long until I receive AndroGel in Minnesota?
›Can I transfer an AndroGel prescription to Minnesota?
›Are 503A pharmacies in Minnesota licensed to ship testosterone gel?
›Who can prescribe AndroGel in Minnesota: MD vs NP vs PA?
›What documentation does prior authorization require in Minnesota?
References
-
AbbVie Inc. AndroGel (testosterone gel) 1% and 1.62% prescribing information. U.S. Food and Drug Administration. Available at: https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021015
-
U.S. Drug Enforcement Administration. Controlled Substances Act, 21 USC 812, Schedules of controlled substances. Available at: https://www.deadiversion.usdoj.gov/21cfr/21usc/812.htm
-
Mulligan T, Frick MF, Zuraw QC, Stemhagen A, McWhirter C. Prevalence of hypogonadism in males aged at least 45 years: the HIM study. Int J Clin Pract. 2006;60(7):762-769. Available at: https://pubmed.ncbi.nlm.nih.gov/17062768/
-
Snyder PJ, Bhasin S, Cunningham GR, et al. Effects of testosterone treatment in older men. N Engl J Med. 2016;374(7):611-624. Available at: https://pubmed.ncbi.nlm.nih.gov/26886521/
-
Minnesota Legislature. Minn. Stat. § 62A.673, Telehealth. Available at: https://www.revisor.mn.gov/statutes/cite/62A.673
-
American Urological Association. Evaluation and management of testosterone deficiency: AUA guideline (2018, amended 2022). Available at: https://www.auanet.org/guidelines-and-quality/guidelines/testosterone-deficiency-guideline
-
Bremner WJ, Vitiello MV, Prinz PN. Loss of circadian rhythmicity in blood testosterone levels with aging in normal men. J Clin Endocrinol Metab. 1983;56(6):1278-1281. Available at: https://pubmed.ncbi.nlm.nih.gov/23454278/
-
Bhasin S, Brito JP, Cunningham GR, et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744. Available at: https://pubmed.ncbi.nlm.nih.gov/31353194/
-
Bhasin S, Cunningham GR, Hayes FJ, et al. Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2010;95(6):2536-2559. Available at: https://pubmed.ncbi.nlm.nih.gov/20525106/
-
Minnesota Board of Medical Practice. License verification and prescribing authority. Available at: https://mn.gov/boards/medical-practice/
-
Bhasin S, Brito JP, Cunningham GR, et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744. Available at: https://pubmed.ncbi.nlm.nih.gov/31353194/
-
Minnesota Department of Human Services. Minnesota Health Care Programs drug policy, testosterone. Available at: https://www.dhs.state.mn.us/main/idcplg?IdcService=GET_DYNAMIC_CONVERSION&RevisionSelectionMethod=LatestReleased&dDocName=dhs16_140357
-
U.S. Food and Drug Administration. Generic drug facts. Available at: https://www.fda.gov/drugs/generic-drugs/generic-drug-facts
-
U.S. Food and Drug Administration. Compounding laws and policies. Available at: https://www.fda.gov/drugs/human-drug-compounding/compounding-laws-and-policies
-
Drug Enforcement Administration. 21 CFR 1306.25, Transfer of a prescription between pharmacies. Available at: https://www.deadiversion.usdoj.gov/21cfr/cfr/1306/1306_25.htm
-
Glueck CJ, Wang P. Testosterone therapy, thrombosis, thrombophilia, cardiovascular events. Metabolism. 2014;63(8):989-994. Available at: https://pubmed.ncbi.nlm.nih.gov/25688234/
-
U.S. Food and Drug Administration. Generic drug facts. Available at: https://www.fda.gov/drugs/generic-drugs/generic-drug-facts